Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 31 to 45 of 72 results for menopause

  1. Laparoscopic removal of uterine fibroids with power morcellation (IPG703)

    Evidence-based recommendations on laparoscopic removal of uterine fibroids with power morcellation in adults. This involves cutting the fibroids into small pieces to remove them.

    Interventional procedures guidance
    Published
    25 August 2021
    View recommendations

    Sections for IPG703

  2. Evidence on the safety of liposuction for chronic lipoedema is inadequate but raises concerns of major adverse events such as fluid imbalance, fat embolism, deep vein thrombosis, and toxicity from local anaesthetic agents. Evidence on the efficacy is also inadequate, based mainly on retrospective studies with methodological limitations. Therefore, this procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page.

    hormonal changes (which should includeeffects seen during puberty and menopause) and the severity and site of disease details of the...

    Research recommendation
    Published
    8 April 2022

  3. Women with breast cancer:- What is the safety and effectiveness of alternatives to systemic HRT as treatments for menopausal symptoms in women who have had treatment for breast cancer?

    treatment. Source guidance details Comes from guidance Menopause: diagnosis and management Number NG23 Date issued

    Research recommendation
    Published
    11 December 2015

  4. Benefits of MRI surveillance in women over 50 years:- Research is recommended to establish the risk and benefits of MRI surveillance compared with mammography in women over 50 years with a personal history of breast cancer. Studies should include sub-analysis for breast density. [new 2013]

    Although breast density decreases with age, and particularly after the menopause, there is no sudden change at any particular age. For...

    Research recommendation
    Published
    9 June 2015

  5. Liposuction for chronic lipoedema (IPG721)

    Evidence-based recommendations on liposuction for chronic lipoedema in adults. This involves using suction to remove abnormal fat.

    Interventional procedures guidance
    Published
    29 March 2022
    View recommendations

    Sections for IPG721

  6. Effects of HRT on venous thromboembolism risk:- How does the preparation of HRT affect the risk of venous thromboembolism (VTE)?

    indicated. Source guidance details Comes from guidance Menopause: diagnosis and management Number NG23 Date issued

    Research recommendation
    Published
    11 December 2015

  7. Pembrolizumab with lenvatinib for previously treated advanced or recurrent endometrial cancer (TA904)

    Evidence-based recommendations on pembrolizumab (Keytruda) with lenvatinib (Lenvima) for treating advanced or recurrent endometrial cancer in adults.

    Technology appraisal guidance
    Published
    21 June 2023
    View recommendations

    Sections for TA904

  8. Quality standards advisory committee 2 members

    Find out more about quality standards advisory committee 2 members at NICE

  9. Heavy menstrual bleeding: assessment and management (NG88)

    This guideline covers assessing and managing heavy menstrual bleeding (menorrhagia). It aims to help healthcare professionals investigate the cause of heavy periods that are affecting a woman’s quality of life and to offer the right treatments, taking into account the woman’s priorities and preferences.

    NICE guideline
    Last updated
    24 May 2021
    View recommendations

    Sections for NG88

  10. Early and locally advanced breast cancer: diagnosis and management (NG101)

    This guideline covers diagnosing and managing early and locally advanced breast cancer. It aims to help healthcare professionals offer the right treatments to people, taking into account the person's individual preferences.

    NICE guideline
    Last updated
    16 January 2024
    View recommendations

    Sections for NG101

  11. Thyroid disease: assessment and management (NG145)

    This guideline covers investigating all suspected thyroid disease and managing primary thyroid disease (related to the thyroid rather than the pituitary gland). It does not cover managing thyroid cancer or thyroid disease in pregnancy. It aims to improve quality of life by making recommendations on diagnosis, treatment, long-term care and support.

    NICE guideline
    Last updated
    12 October 2023
    View recommendations

    Sections for NG145

  12. Depression in adults (QS8)

    This quality standard covers the clinical assessment and management of depression in adults aged 18 and over. It describes high-quality care in priority areas for improvement.

    Quality standard
    Last updated
    29 June 2023
    View quality statements

    Sections for QS8

  13. Urinary incontinence and pelvic organ prolapse in women. Patient decision aid on treating complications from mesh used for stress urinary incontinence – Options for women referred to specialist centres

    think about having surgery later. If you have vaginal symptoms of the menopause it might also help them. However, vaginal oestrogen...

  14. Urinary incontinence and pelvic organ prolapse in women. Patient decision aid on treating complications from mesh used for pelvic organ prolapse – Options for women referred to specialist centres

    think about having surgery later. If you have vaginal symptoms of the menopause it might also help them. However, vaginal oestrogen...

  15. Bisphosphonates for treating osteoporosis (TA464)

    Evidence-based recommendations on the bisphosphonates alendronic acid, ibandronic acid, risedronate sodium and zoledronic acid for treating osteoporosis.

    Technology appraisal guidance
    Last updated
    8 July 2019
    View recommendations

    Sections for TA464